DuPont Water Solutions is a producer of separation and filtration technologies, including reverse osmosis and ultrafiltration membranes, as well as ion exchange resins. While its technologies are critical to the purification of drinking water, many of those same technologies are critical to separations and concentrations across the life science industries to produce food, beverages, therapeutic drugs and diagnostics.  Ion exchange resins also facilitate pharmaceutical formulations and advanced drug delivery when used as excipients or APIs.

The production expansion will be in phases. The first phase—to increase capacity of DuPont’s dedicated cGMP health care supplies units in Chauny, France—is complete with qualifications underway. Future phases—which will focus on increased supply of highly demanded excipient and absorbent products—are expected in the coming years.

“When our customers select one of our products, they count on us to supply not just what they need today, but what they need for the lifetime of their products,” said Condylia Courtney, Global Product Line Manager for Ion Exchange Resins. “This investment demonstrates our commitment to growing with our customers and ensuring supply of their critical excipients.”